期刊文献+

HPLC法测定盐酸帕唑帕尼片含量和有关物质 被引量:2

Content Determination of Main Component and Related Substances in Pazopanib Hydrochloride Tablets by HPLC
原文传递
导出
摘要 目的:建立测定盐酸帕唑帕尼片中主药和有关物质含量的方法。方法:采用高效液相色谱法。色谱柱为KromasilC18,流动相为乙腈-0.02mol·L-1醋酸铵缓冲液(35:65),流速为1.0mL·min-1,检测波长为268nm,柱温为25℃,进样量为20μL。结果:盐酸帕唑帕尼检测浓度线性范围为40.18~361.6μg·mL-1(r=0.9999),检测限为2ng,平均回收率为99.60%,RSD=0.53%(n=9)。结论:该方法操作简便、快捷、准确、可靠,可用于盐酸帕唑帕尼片的质量控制。 OBJECTIVE:To develop a method for the content determination of main component and related substances in Pazopanib hydrochloride tablets.METHODS:HPLC method was adopted.The determination was performed on Kromasil C18 column with mobile phase composed of acetonitrile-0.02 mol·L-1 ammonium acetate solution(35:65) at the flow rate of 1.0 mL·min-1.The detection wavelength was set at 268 nm at 25 ℃.The injection size was 20 μL.RESULTS:The linear range of pazopanib hydrochloride was 40.18~361.6 μg·mL-1(r=0.999 9).The detection limit was 2 ng and average recovery rate was 99.60%(RSD=0.53%,n=9).CONCLUSION:The method is simple,rapid,accurate and reliable,and it is applicable for the quality control of Pazopanib hydrochloride tablets.
出处 《中国药房》 CAS CSCD 2012年第33期3138-3139,共2页 China Pharmacy
关键词 盐酸帕唑帕尼片 有关物质 含量测定 高效液相色谱法 Pazopanib hydrochloride tablets Related substance Content determination HPLC
  • 相关文献

参考文献1

  • 1FDA. FDA approves new treatment for advanced form of kidney cancer[EB /OL]. http://www, fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm 187174.htm.2009- 10-19.2011-08-14.

同被引文献2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部